Status:
UNKNOWN
Pronation During Veno-venous Extra Corporeal Membrane Oxygenation
Lead Sponsor:
University Magna Graecia
Conditions:
Acute Respiratory Distress Syndrome
Acute Respiratory Failure
Eligibility:
All Genders
18+ years
Brief Summary
The Acute Respiratory Distress Syndrome (ARDS) is defined by a recent (within 1 week) respiratory failure, not fully explained by cardiac failure or fluid overload. ARDS is also characterized by bilat...
Eligibility Criteria
Inclusion
- all adult patients with a diagnosis of severe Acute Respiratory Distress Syndrome receiving veno-venous ECMO
Exclusion
- mechanical ventilation for 7 days or longer
- pregnancy
- body mass index (BMI) \> 45 kg/m2
- chronic respiratory failure with long-term oxygen therapy or domiciliary non-invasive ventilation
- cardiac failure resulting in veno-arterial ECMO
- history of heparin- induced thrombocytopenia
- cancer with a life expectancy of less than 5 years
- moribund condition or a Simplified Acute Physiology Score (SAPS-II) value of more than 90;
- current non drug- induced coma after cardiac arrest or presence of an irreversible neurologic injury
- decision to withhold or withdraw life--sustaining therapies
- presence of pneumothorax and/or pulmonary emphysema
- recent (1 week) thoracic surgery
- presence of chest burns
- inclusion in other research protocols
- refusal of consent.
Key Trial Info
Start Date :
February 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
February 28 2023
Estimated Enrollment :
15 Patients enrolled
Trial Details
Trial ID
NCT05198986
Start Date
February 1 2022
End Date
February 28 2023
Last Update
January 20 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Federico Longhini
Catanzaro, Italy, 88100